SWTX Projected Dividend Yield
SpringWorks Therapeutics Inc ( NASDAQ : SWTX )SpringWorks Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer. OGSIVEO (nirogacestat) is the Co.'s Food and Drug Administration (FDA)-approved therapy. OGSIVEO (nirogacestat) is approved in the U.S. for the treatment of adult patients with progressing desmoid tumors who require systemic treatment. Co. also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. 21 YEAR PERFORMANCE RESULTS |
SWTX Dividend History Detail SWTX Dividend News SWTX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |